- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 201/00 - Preparation, separation, purification, or stabilisation of unsubstituted lactams
Patent holdings for IPC class C07D 201/00
Total number of patents in this class: 77
10-year publication summary
2
|
1
|
1
|
9
|
4
|
5
|
6
|
12
|
16
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Patent GmbH | 5864 |
3 |
Mayo Foundation for Medical Education and Research | 3126 |
2 |
Regents of the University of Minnesota | 2687 |
2 |
Vitro Flat Glass LLC | 445 |
2 |
Small Pharma Limited | 18 |
2 |
Technische Universität Dresden Körperschaft des öffentlichen Rechts | 16 |
2 |
Sony Group Corporation | 12811 |
2 |
Merck Sharp & Dohme LLC | 3750 |
2 |
Aexon Labs. Inc. | 2 |
2 |
Unilever PLC | 3309 |
1 |
Unilever N.V. | 3205 |
1 |
Conopco, Inc. | 4840 |
1 |
Boehringer Ingelheim International GmbH | 4748 |
1 |
Pfizer Inc. | 3370 |
1 |
Bayer AG | 3221 |
1 |
Sumitomo Chemical Company, Limited | 9008 |
1 |
Life Technologies Corporation | 3227 |
1 |
Toray Industries, Inc. | 6865 |
1 |
Align Technology, Inc. | 1981 |
1 |
Amicus Therapeutics, Inc. | 355 |
1 |
Other owners | 47 |